STERIS to Discuss Fiscal 2026 Q1 Results in Upcoming Call

STERIS to Discuss First Quarter Results
STERIS plc (NYSE: STE) has exciting news for stakeholders and interested parties alike. The company is set to host a conference call to review its fiscal 2026 first quarter results. This pivotal event is scheduled for 9:00 a.m. ET on August 7, 2025, allowing both analysts and investors to gain insights into the company's performance.
How to Access the Conference Call
Listeners can easily join the conference call by visiting STERIS’s corporate investor relations page. Alternatively, participants can dial 1-833-535-2199 if calling within the United States or 1-412-902-6776 for international calls. By referencing STERIS plc, attendees will be able to access the live briefing efficiently.
Details on Financial Performance Release
As part of its commitment to transparency and communication, STERIS will issue a detailed press release outlining its financial results right after the close of the U.S. market on August 6, 2025. This advance notice ensures that stakeholders stay informed and prepared for discussions during the conference call.
Replay Options for the Conference Call
For those who are unable to tune in live, STERIS will provide a replay of the conference call starting at 12:00 p.m. ET on the same day. Listeners can access the replay both online and via phone. To retrieve the call, users need to use the access code 2889488, dialing 1-877-344-7529 in the U.S. or 1-412-317-0088 for international access.
What STERIS Stands For
STERIS is dedicated to improving patient care through innovative healthcare solutions centered around infection prevention. The company plays a vital role in the healthcare industry, striving to make the world a healthier and safer place through its extensive range of products and services.
Company Contact Information
For additional inquiries, Julie Winter serves as the Vice President of Investor Relations and Corporate Communications at STERIS. She can be reached at +1.440.392.7245 or via email at Julie_Winter@steris.com.
Frequently Asked Questions
What is the purpose of STERIS's conference call?
The conference call aims to discuss the financial performance of STERIS for the first quarter of fiscal 2026, providing insights into business strategies and expectations.
How can I join the conference call?
To join, you can access the call via the internet or by phone using the provided numbers. Ensure to ask for STERIS plc when you call in.
When will the financial results be released?
STERIS will issue its financial results press release after the close of the U.S. stock market on August 6, 2025.
Is there a way to listen to the call later?
Yes, a replay of the conference call will be available starting from 12:00 p.m. ET on August 7, 2025, offering flexibility for listeners who cannot attend the live event.
Who can I contact for more information?
For further information, please contact Julie Winter, Vice President, Investor Relations, through her email or phone as listed above.
About The Author
Contact Hannah Lewis privately here. Or send an email with ATTN: Hannah Lewis as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.